共 50 条
- [42] Use of Pfizer-BioNTech COVID-19 Vaccine in Persons Aged ≥16 Years: Recommendations of the Advisory Committee on Immunization Practices - United States, September 2021 MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT, 2021, 70 (38): : 1344 - 1348
- [44] Intervals Between PCV13 and PPSV23 Vaccines: Recommendations of the Advisory Committee on Immunization Practices (ACIP) (vol 64, pg 944, 2015) MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT, 2015, 64 (42): : 1204 - 1204
- [45] Use of Vaccinia Virus Smallpox Vaccine in Laboratory and Health Care Personnel at Risk for Occupational Exposure to Orthopoxviruses - Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2015 MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT, 2016, 65 (10): : 257 - 262
- [47] Use of Serogroup B Meningococcal Vaccines in Persons Aged ≥ 10 Years at Increased Risk for Serogroup B Meningococcal Disease: Recommendations of the Advisory Committee on Immunization Practices, 2015 MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT, 2015, 64 (22): : 608 - 612
- [48] Use of Updated COVID-19 Vaccines 2023-2024 Formula for Persons Aged ≥6 Months: Recommendations of the Advisory Committee on Immunization Practices - United States, September 2023 MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT, 2023, 72 (42): : 1140 - 1146
- [50] Use of Serogroup B Meningococcal Vaccines in Persons Aged ≥ 10 Years at Increased Risk for Serogroup B Meningococcal Disease: Recommendations of the Advisory Committee on Immunization Practices, 2015 (vol 64, pg 608, 2015) MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT, 2015, 64 (29): : 806 - 806